Standard Biotools Share Price Today
(NASDAQ: LAB)

Name: Standard Biotools Share Price Today (NASDAQ: LAB) - Standard Biotools Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Standard Biotools share price is $1.21 & ₹105.23 as on 6 Mar 2025, 2.30 'hrs' IST

$1.21

▲

0.15

(14.15%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Standard Biotools share price in Dollar and Rupees. Guide to invest in Standard Biotools stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Standard Biotools, along with analyst recommendations, forecasts, and comprehensive financials.

Standard Biotools share price movements

Today's Low: $1.09
Today's High: $1.21
$1.21
10.33%
Downside
Day's Volatility :10.33%
Upside
0.0%
52 Weeks Low: $0.99
52 Weeks High: $3.04
$1.21
18.18%
Downside
52 Weeks Volatility :67.43%
Upside
60.2%

Standard Biotools (LAB) Returns

Period	Standard Biotools Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-39.77%	2.1%	0.0%
6 Months	-45.92%	-4.1%	0.0%
1 Year	-59.23%	2.2%	0.0%
3 Years	-68.82%	11.8%	-11.6%

Standard Biotools (LAB) Key Statistics

in dollars & INR

Previous Close	$1.06
Open	$1.15
Today's High	$1.205
Today's Low	$1.085
Market Capitalization	$394.6M
Today's Volume	$635.3K
52 Week High	$3.04
52 Week Low	$0.99
Revenue TTM	$174.4M
EBITDA	$-117.9M
Earnings Per Share (EPS)	$-0.54
Profit Margin	-79.62%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-43.75%

How to invest in Standard Biotools Stock (LAB) from India?

It is very easy for Indian residents to invest directly in Standard Biotools from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Standard Biotools stock in both Indian Rupees (INR) and US Dollars (USD). Search for Standard Biotools or LAB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Standard Biotools or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Standard Biotools shares which would translate to 0.719 fractional shares of Standard Biotools as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Standard Biotools, in just a few clicks!

Returns in Standard Biotools (LAB) for Indian investors in Rupees

The Standard Biotools stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Standard Biotools investment value today

Current value as on today

₹51,501

Returns

₹48,499

(-48.5%)

Returns from Standard Biotools Stock

₹53,462 (-53.46%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Standard Biotools (LAB)

37%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Standard Biotools Stock from India on INDmoney has increased by 37% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Standard Biotools

Buy

83%Buy

16%Hold

0%Sell

Based on 6 Wall street analysts offering stock ratings for Standard Biotools(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Standard Biotools Stock (LAB)

What analysts predicted

Upside of 96.28%

Target:

$2.38

Current:

$1.21

Insights on Standard Biotools Stock (Ticker Symbol: LAB)

Price Movement
In the last 1 month, LAB stock has moved down by -29.8%
Increasing Revenue
Revenue is up for the last 3 quarters, 37.20M → 46.71M (in $), with an average increase of 10.5% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -26.93M → -34.07M (in $), with an average decrease of 26.5% per quarter
LAB vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 54.6% return, outperforming this stock by 113.5%
LAB vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 135.7% return, outperforming this stock by 205.3%
Price to Sales
ForLAB every $1 of sales, investors are willing to pay $2.1, whereas for Boston Scientific Corp., the investors are paying $9.1 for every $1 of sales.

LAB Standard Biotools Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$117.2M	↑ 3.79%
Net Income	$-64.8M	↑ 9.79%
Net Profit Margin	-55.26%	↓ 3.02%

	FY20	Y/Y Change
Revenue	$138.1M	↑ 17.83%
Net Income	$-53.0M	↓ 18.17%
Net Profit Margin	-38.38%	↑ 16.88%

	FY21	Y/Y Change
Revenue	$130.6M	↓ 5.47%
Net Income	$-59.2M	↑ 11.73%
Net Profit Margin	-45.36%	↓ 6.98%

	FY22	Y/Y Change
Revenue	$97.9M	↓ 24.99%
Net Income	$-190.1M	↑ 220.91%
Net Profit Margin	-194.08%	↓ 148.72%

	FY23	Y/Y Change
Revenue	$106.3M	↑ 8.57%
Net Income	$-74.7M	↓ 60.73%
Net Profit Margin	-70.21%	↑ 123.87%

	FY24	Y/Y Change
Revenue	$174.4M	↑ 64.03%
Net Income	$-184.9M	↑ 147.67%
Net Profit Margin	-106.0%	↓ 35.79%

	Q3 FY23	Q/Q Change
Revenue	$25.4M	↓ 8.31%
Net Income	$-21.0M	↑ 23.22%
Net Profit Margin	-82.77%	↓ 21.18%

	Q4 FY23	Q/Q Change
Revenue	$28.2M	↑ 11.12%
Net Income	$-19.8M	↓ 5.82%
Net Profit Margin	-70.16%	↑ 12.61%

	Q1 FY24	Q/Q Change
Revenue	$45.5M	↑ 61.56%
Net Income	$-32.2M	↑ 62.61%
Net Profit Margin	-70.61%	↓ 0.45%

	Q2 FY24	Q/Q Change
Revenue	$37.2M	↓ 18.3%
Net Income	$-45.7M	↑ 42.17%
Net Profit Margin	-122.88%	↓ 52.27%

	Q3 FY24	Q/Q Change
Revenue	$45.0M	↑ 20.87%
Net Income	$-26.9M	↓ 41.08%
Net Profit Margin	-59.9%	↑ 62.98%

	Q4 FY24	Q/Q Change
Revenue	$46.7M	↑ 3.89%
Net Income	$-34.1M	↑ 26.48%
Net Profit Margin	-72.93%	↓ 13.03%

	FY19	Y/Y Change
Profit	$64.3M	↑ 4.27%

	FY20	Y/Y Change
Profit	$83.3M	↑ 29.63%

	FY21	Y/Y Change
Profit	$77.3M	↓ 7.27%

	FY22	Y/Y Change
Profit	$37.1M	↓ 52.05%

	FY23	Y/Y Change
Profit	$50.5M	↑ 36.16%

	FY24	Y/Y Change
Profit	$84.3M	↑ 67.02%

	Q3 FY23	Q/Q Change
Profit	$11.2M	↓ 18.0%

	Q4 FY23	Q/Q Change
Profit	$13.4M	↑ 19.75%

	Q1 FY24	Q/Q Change
Profit	$24.2M	↑ 81.09%

	Q2 FY24	Q/Q Change
Profit	$14.9M	↓ 38.37%

	Q3 FY24	Q/Q Change
Profit	$23.3M	↑ 56.03%

	Q4 FY24	Q/Q Change
Profit	$21.9M	↓ 5.83%

	FY19	Y/Y Change
Operating Cash Flow	$-35.2M	↑ 39.72%
Investing Cash Flow	$-39.3M	↓ 932.82%
Financing Cash Flow	$2.8M	↓ 95.16%

	FY20	Y/Y Change
Operating Cash Flow	$-15.4M	↓ 56.21%
Investing Cash Flow	$40.0M	↓ 201.71%
Financing Cash Flow	$20.9M	↑ 647.56%

	FY21	Y/Y Change
Operating Cash Flow	$-44.1M	↑ 185.79%
Investing Cash Flow	$-11.9M	↓ 129.88%
Financing Cash Flow	$16.0M	↓ 23.48%

	FY22	Y/Y Change
Operating Cash Flow	$-89.4M	↑ 102.83%
Investing Cash Flow	$-88.1M	↑ 637.71%
Financing Cash Flow	$230.8M	↑ 1345.94%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-9.3M	↑ 9.95%
Investing Cash Flow	$40.1M	↓ 7.02%
Financing Cash Flow	$-2.1M	↓ 18.53%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-11.4M	↑ 22.33%
Investing Cash Flow	$33.4M	↓ 16.88%
Financing Cash Flow	$-1.2M	↓ 44.15%

Standard Biotools Technicals Summary

Sell

Neutral

Buy

Standard Biotools is currently in a neutral trading position according to technical analysis indicators.

Standard Biotools (LAB) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Standard Biotools Inc	-27.89%	-45.92%	-59.23%	-68.82%	-61.17%
Medtronic Plc	2.26%	4.07%	8.74%	-12.76%	0.68%
Edwards Lifesciences Corp.	0.07%	8.12%	-19.19%	-34.12%	12.08%
Boston Scientific Corp.	0.07%	27.33%	53.68%	143.5%	203.93%
Stryker Corporation	-0.63%	8.92%	9.84%	53.87%	125.87%
Abbott Laboratories	7.11%	21.64%	15.28%	15.75%	78.63%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Standard Biotools Inc	NA	NA	NA	-0.15	-0.44	-0.18	NA	1.23
Medtronic Plc	28.75	28.75	1.87	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	30.5	30.5	5.57	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	83.9	83.9	1.85	2.86	0.09	0.05	NA	14.76
Stryker Corporation	50.89	50.89	2.85	13.49	0.15	0.07	0.01	54.1
Abbott Laboratories	18.34	18.34	2.52	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Standard Biotools Inc	Buy	$394.6M	-61.17%	NA	-79.62%
Medtronic Plc	Buy	$120.9B	0.68%	28.75	12.83%
Edwards Lifesciences Corp.	Buy	$42.0B	12.08%	30.5	76.75%
Boston Scientific Corp.	Buy	$154.8B	203.93%	83.9	11.07%
Stryker Corporation	Buy	$150.7B	125.87%	50.89	13.25%
Abbott Laboratories	Buy	$238.6B	78.63%	18.34	31.95%

About Standard Biotools

Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Organization	Standard Biotools
Employees	0
CEO	Dr. Michael Egholm Ph.D.
Industry	Technology

Management People of Standard Biotools

Name	Title
Dr. Michael Egholm Ph.D.	President, CEO & Director
Mr. Hanjoon Kim	Chief Financial Officer
Mr. Jonathan Mickelsen	VP & Chief Accounting Officer
David Holmes	Investor Relations
Mr. Sean Mackay	Chief Business Officer & Senior VP
Dr. Stephen A. Williams BS, MB, Ph.D.	Chief Medical Officer

Important FAQs about investing in LAB Stock from India :

What is Standard Biotools share price today?

Standard Biotools share price today stands at $1.21, Open: $1.15 ; Previous Close: $1.06 ; High: $1.21 ; Low: $1.09 ; 52 Week High: $3.04 ; 52 Week Low: $0.99.

The stock opens at $1.15, after a previous close of $1.06. The stock reached a daily high of $1.21 and a low of $1.09, with a 52-week high of $3.04 and a 52-week low of $0.99.

Can Indians buy Standard Biotools shares?

Yes, Indians can invest in the Standard Biotools (LAB) from India.

With INDmoney, you can buy Standard Biotools at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Standard Biotools at zero transaction cost.

How can I buy Standard Biotools shares from India?

It is very easy to buy Standard Biotools from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Standard Biotools (LAB) be purchased?

Yes, you can buy fractional shares of Standard Biotools with INDmoney app.

What are the documents required to start investing in Standard Biotools stocks?

To start investing in Standard Biotools, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.